Relationship between physical activity and abdominal obesity and metabolic markers in postmenopausal women Authors: Yangjun Liu, Sujie Mao, Wei Xie, Humińska-Lisowska Kinga Agnieszka, Sawczyn Monika Helena, Dzitkowska-Zabielska Magdalena, Guoping Qian, Zbigniew Ossowski Published: 2024 ABSTRACT This study aimed to investigate the impact of physical activity indicators monitored by the POLAR accelerometer on body obesity indicators, metabolic syndrome parameters, and energy metabolism hormones in postmenopausal women. Was included 71 participants from this study program (68.8 ± 4.3 years). We divided participants into LPA and MVPA groups based on their level of moderate to vigorous physical activity per week; Physical activity levels over 7 days were assessed using a POLAR accelerometer, with daily step counts and sedentary time recorded. Measurements included waist circumference, visceral fat volume, body fat percentage, blood pressure, fasting blood glucose, triglyceride levels, HDL cholesterol, and energy metabolism hormone levels (leptin, resistin, adiponectin). The MVPA group displayed lower waist circumference, body fat percentage, abdominal fat, and BMI compared to the LPA group (p < 0.05). A significant negative correlation was observed between daily step count and obesity indicators, including waist circumference (r = -0.301), body fat percentage (r = -0.295), abdominal fat (r = -0.318), and BMI (r = -0.238). Conversely, sedentary time showed a positive correlation with obesity indicators such as waist circumference (r = 0.258), body fat percentage (r = 0.239), and abdominal fat (r = 0.244). Moreover, daily step count exhibited a significant negative correlation with leptin levels (r = -0.245), while sedentary time was positively correlated with the energy metabolic factor leptin (r = 0.279). Waist circumference demonstrated significant positive correlations with triglycerides, blood glucose, adiponectin, resistin, and leptin levels. Postmenopausal women who engage in at least 150 min of MVPA weekly show lower obesity indices. There is a significant correlation between physical activity levels and obesity indicators, which relate to metabolic syndrome and energy metabolism factors. Thus, increased physical activity may help prevent metabolic syndrome and cardiovascular diseases in this population. Introduction The global prevalence of obesity and overweight individuals, as highlighted by the World Health Organization (WHO), underscores the pressing need to address these conditions due to their significant association with noncommunicable diseases. Obesity serves as a prominent risk factor for various health issues, including cardiovascular diseases, metabolic syndrome (notably diabetes), musculoskeletal disorders (particularly osteoarthritis), cancer, and other ailments1. Postmenopausal women are particularly vulnerable to central obesity, primarily attributed to hormonal fluctuations that alter lipid metabolism within the body2,3. Central obesity, characterized by an increase in waist circumference and the accumulation of visceral fat, is closely linked to adverse lipid profiles, insulin resistance, elevated diastolic blood pressure4, arterial stiffness, and overall compromised cardiovascular health5. becoming a major risk factor for metabolic syndrome6,7. Abdominal obesity was recognized globally as a crucial clinical indicator for the early identification of cardiovascular disease and type 2 diabetes8,9, individuals with metabolic syndrome face a twofold higher risk of cardiovascular ailments and a fivefold higher risk of developing type 2 diabetes10,11. The accumulation of abdominal fat can trigger the release of various adipokines, including leptin, resistin, and adiponectin, which serve as key energy metabolism hormones with blood levels serving as biomarkers associated with obesity12. Leptin plays a pivotal role in energy regulation by suppressing appetite and boosting energy expenditure, and its levels have been linked to abdominal obesity and insulin resistance13. Large-scale cross-sectional studies have demonstrated a significant positive correlation between leptin levels and metabolic syndrome14,15. Resistin, on the other hand, may act as a molecular bridge between inflammation, metabolic parameters, and vascular dysfunction, thereby heightening the risk of metabolic syndrome, type 2 diabetes, and cardiovascular diseases16,17. Adiponectin exerts regulatory effects on blood glucose levels, lipid metabolism, and insulin sensitivity through its anti-inflammatory, anti-fibrotic, and antioxidant properties. Unlike other adipogenic factors, adiponectin exhibits an inverse relationship with obesity18. Numerous studies have indicated that weight loss, including reductions in body fat, is accompanied by elevated circulating adiponectin levels19. An increase in body mass index (BMI) has been associated with decreased plasma adiponectin concentrations and increased resistin and leptin levels12,20. Understanding the intricate interplay between physical activity, obesity indicators, and metabolic markers in postmenopausal women is crucial for devising effective strategies to combat the burgeoning health challenges posed by obesity-related conditions. Postmenopausal women, particularly those grappling with central obesity, face an elevated susceptibility to metabolic syndrome (MetS), type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), and cardiovascular disease (CVD)21–27. Mitigating obesity and closely monitoring metabolic parameters and adipokines are crucial steps in safeguarding their well-being28–30. Physical activity emerges as a pivotal tool in enhancing the physical health of postmenopausal women, with numerous studies underscoring its role in preventing and managing obesity and overweight, improving metabolic syndrome markers, and modulating inflammatory indicators31,32. Exploring the intricate relationships between leptin, resistin, adiponectin, and various anthropometric and body composition parameters in physically active postmenopausal women has unveiled significant associations32. Beyond mitigating overweight risks, physical activity contributes to enhancing body composition, bolstering muscle strength, curbing low-grade chronic inflammation, and optimizing energy-metabolizing hormone levels33,34. Studies leveraging accelerometer-based assessments of physical activity have demonstrated its efficacy in ameliorating metabolic syndrome markers36–38, exerting a protective influence in diabetes mellitus management37,39, and boosting adiponectin levels41. However, divergent findings have been reported in certain investigations40,41. While existing literature predominantly delves into the impact of physical activity on obesity, metabolic parameters, and energy-metabolizing hormones, a comprehensive exploration of the interplay between accelerometer-monitored physical activity levels, obesity indices, metabolic syndrome parameters, and energy-metabolizing hormones in postmenopausal women remains scarce. This study seeks to unravel the collective effects of physical activity indicators monitored through POLAR accelerometers on body obesity metrics, metabolic syndrome parameters, and energy metabolism hormones in postmenopausal women. By elucidating these intricate relationships, we aim to advance our understanding of how physical activity influences metabolic health in this vulnerable population subset. Materials and methods Ethics This study received approval from the Bioethics Committee of t the District Medical Chamber in Gdańsk in compliance with the Declaration of Helsinki under procedure number KB-5/22. Prior to commencement, all participants were provided with a detailed verbal and written explanation of the study and gave informed consent by signing a consent form. Participants These individuals were selected from a pool of 680 women who initially consented to screening and attended various lectures at the University of the Elderly. Finally, the results of 71 people were included in the analysis (Fig. 1). Fig. 1Sampling flowchart. Sampling flowchart. Each participant underwent a comprehensive medical assessment before inclusion in the study. While cognitive function assessments were not utilized as eligibility criteria, participants were required to independently respond to questions during face-to-face interviews without external assistance. Inclusion criteria:Postmenopausal women (defined as those who experienced their last menstrual period 12 months ago). Postmenopausal women (defined as those who experienced their last menstrual period 12 months ago). Postmenopausal women (defined as those who experienced their last menstrual period 12 months ago). Exclusion criteria: Uncontrolled hypertension.Oophorectomy.Rheumatoid arthritis.Pulmonary disease.Type 2 diabetes mellitus requiring insulin therapy. Uncontrolled hypertension. Uncontrolled hypertension. Oophorectomy. Oophorectomy. Rheumatoid arthritis. Rheumatoid arthritis. Pulmonary disease. Pulmonary disease. Type 2 diabetes mellitus requiring insulin therapy. Type 2 diabetes mellitus requiring insulin therapy. All participants underwent a thorough physical examination to ensure they had no contraindications to physical activity. Participants were also asked to disclose information regarding any prescribed medications, with those taking medications receiving ongoing supervision from a medical specialist to monitor dosage. To minimize potential confounding variables, medication type and dosage remained constant throughout the study period. Seventy-one participants completed accelerometer measurements, provided fasting blood samples, and underwent anthropometric assessments. Population characteristics were as follows: Based on national classification, 32 participants met the criteria for overweight (BMI ≥ 25 kg/m²), 17 participants met the criteria for obesity (BMI ≥ 30 kg/m²), and all 55 participants had waist circumference exceeding the cut-off (80 cm for women). Regarding metabolic syndrome criteria, only 7 (9.5%) participants exhibited no risk factors, 52 (70.2%) had 1–2 risk factors, and 12 (16.2%) had 3 or more risk factors for metabolic syndrome. Measures Assessment of body composition and anthropometry Height and Waist Circumference: Height and waist circumference were measured with a precision of 0.1 cm. Height was measured with the participant barefoot in an upright position, while waist circumference was measured horizontally around the abdomen at the highest point of the iliac crest and the midpoint of the line connecting the lower border of the 12th rib, ensuring the soft ruler remained horizontal and pressed against the skin without compression. Body Weight, Body Fat Percentage (i.e. Visceral Fat Area – VFA and body fat percentage - PBF) and Fitness Score were assessed using the Octapole Bioimpedance InBody 720 analyzer (Biospace, Seoul, South Korea) following a standard protocol. The Fitness Score is an indicator that assesses overall health and physical condition. It is calculated based on several factors, including the ratio of muscle mass to fat mass, age and gender, as well as the level of body fat. Participants wore light clothing and no shoes during the measurement. The analyzer utilizes eight contact electrodes placed on specific body parts to analyze body composition at various frequencies (1, 5, 50, 250, 500, and 1,000 kHz). The device allows independent analysis of five basic body segments. BMI was calculated as BM/height² (kg/m²). Laboratory testing Blood Pressure Measurement: Resting systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded using the Omron HEM-907XL device (Omron Healthcare, Inc., IL, USA). Blood Sample Collection and Analysis: Fasting venous blood samples were obtained after a minimum 12-hour overnight fast. Blood samples were collected in Sarstedt S-Monovette tubes without anticoagulants but with coagulation promoters for serum fractionation. Serum samples were processed using standard laboratory procedures, aliquoted, and stored at -80 °C until analysis. Markers Analysis: (1) Metabolic syndrome detection indicators: total cholesterol, triglycerides, high-density cholesterol (HDL), low-density cholesterol (LDL), non-high-density cholesterol NO-HDL and fasting blood glucose levels. (2) Furthermore, levels of various markers including adiponectin, leptin, and resistin were determined. Analysis was performed using the MAGPIX fluorescence detection system (Luminex Corp., Austin, TX, USA) and the Luminex assay (Luminex Human Magnetic Assay 5-Plex) following the manufacturer’s protocols. The standard curves for each analyzete spanned the following concentration ranges: adiponectin (466–340,000pg/mL), leptin (50–36,500pg/mL), resistin (46–33,200pg /mL), The assay sensitivities (lower limits of detection) were 6.4pg/mL for adiponectin, 7.69pg/mL for leptin and 0.85pg/mL for resistin. The intra-assay coefficient of variation (CV) limit was set at 20%, and all measurements fell within this range. Recovery rates for the assays ranged between 80% and 120%. All samples were analyzed in duplicate to ensure accuracy and reproducibility. Data acquisition and analysis were performed using xPONENT software and Bio-Techne’s Quantist Luminex data analysis software (Luminex Corp., Austin, TX, USA). Prior to testing, participants were advised to stay hydrated, limit physical activity the day before, and remain inactive the night before and the morning of the test. Other variables Demographic and Health Information: Information on age, ethnicity, educational status, smoking history, and medication use for diabetes, hypertension, and dyslipidemia was collected through face-to-face interviews with participants. Physical activity The World Health Organization’s physical activity guidelines state that adults should engage in aerobic and muscle-strengthening physical training every week; On average, 150–300 min per week of moderate intensity or 75–150 min of vigorous intensity, or equivalent MVPA combination training can be observed to observe the many benefits of physical activity on physical health. Guidelines also recommend that adults over 65 years of age should engage in moderate- or higher-intensity multicomponent physical activity three or more days per week to enhance functional capacity and prevent falls42. Barbara E. et al. standardized the intensity of each physical activity in the “Physical Activity Compendium”43; The energy expenditure of various physical activities has been further elaborated by Herrmann SD et al.44. Based on the above theories and methods, the intensity of physical activity monitored by POLAR accelerometer was grouped in this study. Data Inclusion Criteria: A valid measurement day was defined as a monitor wear time of at least 600 min/day. Participants with at least four days of valid accelerometer measurement activities were included in the analysis, with an average of 7 valid measurement days. The first and last measurement days were excluded from the analysis. Activity Categories: (1) Sedentary Time (ST): Lying and sitting time measured by the accelerometer (≤ 1.99 MET). (2) Light Physical Activity (LPA) Time: Standing and walking time measured by the accelerometer (2.00–3.49 MET). (3) Moderate to Vigorous Physical Activity (MVPA) Time: Recorded for moderate and above strenuous exercise time and capacity expenditure (≥ 3.50 MET) measured by the accelerometer. Participants were categorized into LPA group (moderate intensity activity < 150 min/week) and MVPA group (moderate to vigorous intensity activity ≥ 150 min/week). Statistical analysis Mean and standard deviation (SD) of all measured variables were calculated. Differences between MVPA and LPA groups were evaluated using t-tests. Adjusted multiple linear regression was conducted to assess the association between physical activity and abdominal obesity, metabolic syndrome, and energy metabolism factors. A regression model was developed using steps, physical activity time, MVPA time, and sedentary time as explanatory variables. The regression model was adjusted for potential confounders including gender, age, body mass index, education, accelerometer wear time, step count, and walking time. The analysis aimed to determine the relationship between specific physical activity metrics and obesity, metabolic syndrome, and inflammatory factors in menopausal women. Significance level was set at p < 0.05. Statistical analyses were performed using IBM SPSS Statistics program. Results Comparison between MVPA and LPA groups The average accelerometer wearing time was 21.64 (SD 3.33) hours/day, with an average measurement duration of 7 (SD 2) days. Participants spent 73.85% (SD 7.81) of their accelerometer wear time on sedentary activities and took an average of 11,196 steps per day (SD 4,267). Statistically significant differences were observed in BMI, body fat mass, visceral fat area, and waist circumference between the LPA and MVPA groups. Significant differences were also noted in performance scores, mean activity time, daily steps, and sedentary ratio between the groups, with no significant differences in metabolic and energy metabolizing hormones (See Table 1). Table 1Characteristics of the study participants by physical activity.VariablesLPA groupMVPA<150 min/weekMVPA groupMVPA ≥ 150 min/weekn, (% of total)42(59)29(41)Age, years69(4.2)68.6(4.4)Anthropometrics Height (cm)158.1 (5.8)162.5(5.2)** Weight (kg)71.7(11.8)68.4(10.6) BMI28.6(4.3)25.9(3.9) ** BFM (%)29.1(8.7)24(8.7)* VFA117.9(30.2)100.6(30.1)* WC (cm)93.1(12.5)86.2(11.6)* Fitness Score64.7(6.7)69.9(7.3)**Metabolic syndrome parameters SBP (mmHg)126.8(18.4)135.0(19.4) DBP (mmHg)75.6(9.9)78.5 (8.9) Glucose (mg/dl)98.8(23.8)96.9(26.9) TG (mg/dl)105.9(53.0)108.4(39.7) HDL (mg/dl)65.9(14.3)64.3(12.3) NO-HDL (mg/dl)152.4(44.2)158.1(34.4) LDL (mg/dl)131.2(40.5)132.9(35.3) TC (mg/dl)218.4(44.1)222.3(37.5)Energy metabolism hormones Adiponectin (pg/ml)125035.5(63159.9)121078.3(35559.7) Leptin (pg/ml)11721.8(11154.6)7830.8(9197.4) Resistin (pg/ml)14324.4(6454.8)12459.3(5178.1)Accelerometer measurements Accelerometry (days)77 Average activity time (min/day)313.7(93.0)362.1(102.5)* Mean kilocalories burned (kcal)1710.3(192.2)1792.6(211.8) Daily steps9890(3794)13,089(4262)* MVPA (min /week)50.4(38.3)274.7(166.1)*** LPA (min / day)306.0 (90.6)326.2 (97.6) ST proportion/day, (%)0.75(0.08)0.72(0.08)*The results are reported as the mean (SD). Significant p-values: * p < 0.05, ** p < 0.01, ***< 0.001. Table 1Characteristics of the study participants by physical activity.VariablesLPA groupMVPA<150 min/weekMVPA groupMVPA ≥ 150 min/weekn, (% of total)42(59)29(41)Age, years69(4.2)68.6(4.4)Anthropometrics Height (cm)158.1 (5.8)162.5(5.2)** Weight (kg)71.7(11.8)68.4(10.6) BMI28.6(4.3)25.9(3.9) ** BFM (%)29.1(8.7)24(8.7)* VFA117.9(30.2)100.6(30.1)* WC (cm)93.1(12.5)86.2(11.6)* Fitness Score64.7(6.7)69.9(7.3)**Metabolic syndrome parameters SBP (mmHg)126.8(18.4)135.0(19.4) DBP (mmHg)75.6(9.9)78.5 (8.9) Glucose (mg/dl)98.8(23.8)96.9(26.9) TG (mg/dl)105.9(53.0)108.4(39.7) HDL (mg/dl)65.9(14.3)64.3(12.3) NO-HDL (mg/dl)152.4(44.2)158.1(34.4) LDL (mg/dl)131.2(40.5)132.9(35.3) TC (mg/dl)218.4(44.1)222.3(37.5)Energy metabolism hormones Adiponectin (pg/ml)125035.5(63159.9)121078.3(35559.7) Leptin (pg/ml)11721.8(11154.6)7830.8(9197.4) Resistin (pg/ml)14324.4(6454.8)12459.3(5178.1)Accelerometer measurements Accelerometry (days)77 Average activity time (min/day)313.7(93.0)362.1(102.5)* Mean kilocalories burned (kcal)1710.3(192.2)1792.6(211.8) Daily steps9890(3794)13,089(4262)* MVPA (min /week)50.4(38.3)274.7(166.1)*** LPA (min / day)306.0 (90.6)326.2 (97.6) ST proportion/day, (%)0.75(0.08)0.72(0.08)*The results are reported as the mean (SD). Significant p-values: * p < 0.05, ** p < 0.01, ***< 0.001. Characteristics of the study participants by physical activity. The results are reported as the mean (SD). Significant p-values: * p < 0.05, ** p < 0.01, ***< 0.001. Correlation between physical activity and obesity parameters The study found that the average daily steps of participants were negatively correlated with BFM (r = -0.295, p = 0.012) as shown in Fig. 2a. the average daily steps were also negatively correlated with WC (r = -0.303, p = 0.010), as depicted in Fig. 22b; negatively correlated with VFA (r = -0.318, p = 0.007), as illustrated in Fig. 2c; and negatively correlated with BMI (r = -0.238, p = 0.045), as seen in Fig. 2d. Additionally, the study revealed that the weekly duration of moderate to vigorous physical activity was negatively correlated with BFM (r = -0.248, p = 0.037), as shown in Fig. 3a; negatively correlated with WC (r = -0.282, p = 0.017), as presented in Fig. 33b; and negatively correlated with VFA (r = -0.245, p = 0.040), as illustrated in Fig. 33c; however, the correlation with BMI was not significant. Furthermore, the results showed that the proportion of sedentary time during the day was positively correlated with BFM (r = 0.239, p = 0.045), as depicted in Fig. 4a; positively correlated with WC (r = 0.258, p = 0.030), as shown in Fig. 4b; and positively correlated with VFA (r = 0.244, p = 0.040), as illustrated in Fig. 4c; however, the correlation with BMI was not significant. The correlation analysis results of physical activity metrics with obesity parameters are presented in Table 2. Table 2Correlation analysis between physical activity indicators and obesity indicators.variablesBFMWCVFABMIPA parameter Daily steps− 0.295*− 0.303*− 0.318**− 0.238* MVPA (min/week)− 0.248*− 0.282*− 0.245*− 0.227 LPA (min/day)− 0.098− 0.099− 0.118− 0.063 Average activity time (min/day)− 0.155− 0.157− 0.178− 0.115 ST proportion (%)0.239*0.258*0.244*0.214Significant p-values: * p < 0.05, ** p < 0.01; minus sign means negative correlation. Table 2Correlation analysis between physical activity indicators and obesity indicators.variablesBFMWCVFABMIPA parameter Daily steps− 0.295*− 0.303*− 0.318**− 0.238* MVPA (min/week)− 0.248*− 0.282*− 0.245*− 0.227 LPA (min/day)− 0.098− 0.099− 0.118− 0.063 Average activity time (min/day)− 0.155− 0.157− 0.178− 0.115 ST proportion (%)0.239*0.258*0.244*0.214Significant p-values: * p < 0.05, ** p < 0.01; minus sign means negative correlation. Correlation analysis between physical activity indicators and obesity indicators. Significant p-values: * p < 0.05, ** p < 0.01; minus sign means negative correlation. Fig. 2Correlation of daily steps with obesity parameters. Correlation of daily steps with obesity parameters. Fig. 3Correlation of MVPA with obesity parameters. Correlation of MVPA with obesity parameters. Fig. 4Correlation of sedentary time proportion per day (%) with obesity parameters. Correlation of sedentary time proportion per day (%) with obesity parameters. Correlation between physical activity and metabolic parameters and energy metabolism hormones Daily step count showed a negative correlation with leptin (P < 0.05), while sedentary time was positively correlated with leptin (P < 0.05) (refer to Figs. 5 and 6). No significant correlation between daily steps, daily activity duration, MVPA time, and daily sedentary time was observed in the results with other metabolic parameters and energy-metabolizing hormones. Fig. 5Correlation between steps/day and Leptin. Correlation between steps/day and Leptin. Fig. 6Correlation of Sedentary time proportion per day (%) and Leptin. Correlation of Sedentary time proportion per day (%) and Leptin. Correlation between obesity parameters and metabolic parameters and energy metabolism hormones Waist circumference was positively correlated with metabolic markers DBP, TG, and glucose (p < 0.05). Body fat mass (BFM), visceral fat area (VFA), and BMI were positively correlated with blood glucose (p < 0.05) (refer to Table 3). Waist circumference, BFM, VFA, BMI, and energy metabolism hormones adiponectin, leptin, and resistin were significantly positively correlated (refer to Table 4). Table 3Correlation analysis results between obesity parameters and metabolic factors.SBPDBPTCTGHDLNO-HDLLDLGlucoseWC0.0850.249*-0.0630.286*-0.2290.011-0.1210.409**BFM0.0400.224-0.0430.200-0.2050.024-0.0600.278*VFA0.1250.294*-0.0280.221− 0.01900.034-0.0510.326**BMI0.0300.198-0.0470.185-0.1840.012-0.0670.256*Significant p-values: * p < 0.05, ** p < 0.01. Table 3Correlation analysis results between obesity parameters and metabolic factors.SBPDBPTCTGHDLNO-HDLLDLGlucoseWC0.0850.249*-0.0630.286*-0.2290.011-0.1210.409**BFM0.0400.224-0.0430.200-0.2050.024-0.0600.278*VFA0.1250.294*-0.0280.221− 0.01900.034-0.0510.326**BMI0.0300.198-0.0470.185-0.1840.012-0.0670.256*Significant p-values: * p < 0.05, ** p < 0.01. Correlation analysis results between obesity parameters and metabolic factors. Significant p-values: * p < 0.05, ** p < 0.01. Table 4Correlation analysis results between obesity parameters and energy metabolism hormones.AdiponectinLeptinResistinWC0.378**0.656**0.389**BFM0.306**0.660**0.397**VFA0.307**0.623**0.419**BMI0.278*0.659**0.371**Significant p-values: * p < 0.05, ** p < 0.01. Table 4Correlation analysis results between obesity parameters and energy metabolism hormones.AdiponectinLeptinResistinWC0.378**0.656**0.389**BFM0.306**0.660**0.397**VFA0.307**0.623**0.419**BMI0.278*0.659**0.371**Significant p-values: * p < 0.05, ** p < 0.01. Correlation analysis results between obesity parameters and energy metabolism hormones. Significant p-values: * p < 0.05, ** p < 0.01. Discussion The study results suggest that the number of steps per day in postmenopausal women was significantly negatively correlated with obesity indicators, waist circumference, body fat, abdominal fat and BMI. There was a positive correlation between sedentary time proportion per day and obesity indicators. It was also noted that number of steps per day was negatively correlated with leptin while the proportion of sedentary time in a day was positively correlated with the energy metabolism factor leptin. Moreover, waist circumference was positively correlated with metabolic and cardiovascular indicators, such as triglycerides, blood glucose, adiponectin, resistin and leptin. In our study, we observed that participants with low MVPA levels had a higher proportion of sedentary time and higher obesity indicators, and that step count was negatively correlated with obesity parameters, and sedentary time was significantly positively correlated with obesity parameters. Several studies have reported a higher proportion of sedentary time in older adults who use hip-worn accelerometers45,46. In a study of a cohort of elderly people in the Netherlands, participants were sedentary for an average of 65% of their total wearing time, 33% for LPA, and 2% for MVPA using the same triaxial accelerometer worn on the hip48. Low levels of physical activity and excessive sedentary time50 put older adults at increased risk for a variety of harmful health outcomes, including all-cause mortality, metabolic syndrome, obesity, and cognitive health [51–53]. Studies have shown that moderate to vigorous PA (MVPA) at recommended levels is inversely associated with markers of overweight and obesity, such as BMI and waist circumference, in older adults52,53. Evidence from multiple studies suggests a positive correlation between sedentary behavior (primarily watching television) and the risk of overweight and obesity56–58. Therefore, encouraging postmenopausal women to increase the duration of MVPA activities, reduce daily sedentary time and increase the number of steps walked will directly improve their obesity indicators and play a role in preventing cardiovascular and metabolic diseases. Leptin, resistin, and adiponectin are energy-metabolizing hormones, and their blood levels have been associated with obesity and obesity biomarkers57. In this study, we observed a negative correlation between daily step count and leptin. Leptin may be a contributing factor to obesity and related diseases in humans58. Inhibition of leptin production has been shown to reduce the severity of central obesity59. Several studies have shown that exercise decreases resistin and leptin levels and increases adiponectin concentrations60,61. This is consistent with the results of the leptin study observed in our study. Waist circumference is an important marker of abdominal obesity and one of the evaluation indicators of metabolic syndrome, which can accurately predict cardiometabolic risk65. In our study, we found that the lower the level of physical activity, i.e., the fewer steps per day, the more sedentary time participants with less PA or MVPA activity and the greater the value of obesity parameters such as waist circumference. Physical activity indicators, such as steps, MVPA time, PA time, and sedentary time, all directly affected waist circumference, and waist circumference was significantly positively correlated with triglycerides, blood glucose, adiponectin, resistin, and leptin. This result is consistent with previous findings on a negative correlation between PA and WC measured by accelerometers63,65,66. Low waist circumference is a strong predictor of good metabolic health, while high waist circumference is a risk factor for metabolic diseases such as type 2 diabetes69,70. In older adults, high MVPA and PA are associated with lower WC71,72, while high sedentary time is associated with higher waist circumference and body mass index (BMI)68. Individuals with altered cardiometabolic markers, such as large waist circumference (WC)72, higher blood pressure69, and higher concentrations of high triglycerides and low-density lipoprotein cholesterol (LDL-c)71, were found to have a higher risk of CVD. The adipokines adiponectin, resistin, and leptin are potential biomarkers of metabolic syndrome in postmenopausal women. Therefore, from our study, we can see that physical activity levels can indirectly affect indicators of metabolic syndrome and energy metabolism factor levels by influencing obesity parameters such as waist circumference in postmenopausal women. However, in this study, I observed a positive correlation between waist circumference and adiponectin levels, contrary to the findings of the randomized controlled trial conducted by Miller EG et al.75 and Hasegawa N et al.72. This may be due to the small number of people included in the study array, large individual differences in the population. Our results are similar to those reported by Newton et al. (2013), who observed a lower prevalence of MetS compared to participants with higher daily step counts73. One meta-analysis showed a gradual decrease in the risk of death in older adults who accumulated at least 3000 steps per day and recommended increasing the number of steps to between 6000 and 8000 steps per day74. Recently, Paluch et al. (Paluch et al., 2023, Paluch et al., 2022) showed in a unified meta-analysis that 6000 to 9000 steps per day was associated with a 40 to 50% reduction in the risk of CVD events in older adults74,75. These meta-analyses also confirm our findings that increasing physical activity levels, such as daily steps or MVPA time, can help reduce health risks. Strengths and limitations The strengths of this study include: (1) The utilization of POLAR accelerometers for monitoring exercise indicators, providing objective and reliable data on daily steps, activity time, and sedentary time. (2) Analysis of the relationship between physical activity and metabolic and energy metabolic factors, as well as exploring the indirect impact of exercise indicators on abdominal obesity and energy metabolic factors. However, there are several limitations to the current research: (1) The study was conducted at Gdansk University of Physical Education in Poland with a highly homogeneous study population, raising questions about the generalizability of the results to women of different ethnicities or those residing in developing countries with less robust healthcare systems. (2) Prolonged wear of accelerometers may lead to confusion between sleep and sedentary time. (3) The small sample size in the included studies could result in discrepancies from similar studies, such as the relationship between adiponectin and exercise in relation to waist circumference. (4) The cross-sectional nature of the study prevents establishing a causal relationship between physical activity levels and indicators of metabolic syndrome and energy metabolism. Despite these limitations, the study revealed varying correlations between physical activity, sedentary behaviors, obesity indicators, abdominal obesity, and metabolic syndrome indicators among the 71 individuals studied. The results of this study may help elderly women improve their lifestyle and exercise habits, and provide a reference for coaches, physiotherapists, doctors and other professionals engaged in the prevention and treatment of metabolic diseases. Conclusion In summary, postmenopausal women engaging in MVPA for 150 min or more per week exhibited significantly lower obesity indices compared to those with lower activity levels. Furthermore, there was a notable correlation between physical activity levels and obesity indicators, which were also related to leptin levels. Obesity indicators such as WC were closely associated to indicators of metabolic syndrome and energy metabolism factors. Physical activity levels can influence metabolic and energy metabolism factors by affecting obesity indicators, potentially aiding postmenopausal women in preventing metabolic syndrome and cardiovascular diseases.